Psychiatric medication management for Palm Beach Gardens — measurement-based, in-person.

Palm Beach Gardens residents from PGA National, Mirasol, and BallenIsles drive 35 minutes south to RECO Integrated Psychiatry because the clinical density available in Delray Beach is not matched by general outpatient practices in northern Palm Beach County. Initial evaluations run 60-90 minutes and produce a documented DSM-5-TR formulation — not a symptom checklist. Follow-ups are anchored to PHQ-9, GAD-7, and disorder-specific scales tracked visit-over-visit, and the medication algorithm does not stall at sertraline plus bupropion when augmentation, cross-class switching, pharmacogenomic testing, and escalation to rTMS or Spravato are on the table.

Palm Beach Gardens sits 25 miles north of RECO Integrated Psychiatry’s Delray Beach office — roughly 35 minutes down I-95 for residents of BallenIsles, Mirasol, Frenchman’s Reserve, Old Palm, and PGA National. For adults whose depression, anxiety, bipolar disorder, ADHD, PTSD, or OCD has outlasted an SSRI trial started in primary care, the drive south reaches a specialty outpatient psychiatry practice built around structured diagnostic workups, measurement-based care, and the full pharmacologic toolkit — a level of clinical density that general outpatient practices in northern Palm Beach County typically do not deliver.

What a real psychiatric evaluation actually covers

The initial visit at RECO runs 60-90 minutes and produces a documented DSM-5-TR diagnostic formulation — not a symptom checklist. History includes prior medication trials with specific doses, durations, and reasons for discontinuation; a three-generation family psychiatric history; a validated substance use screen; and, where clinically relevant, a trauma history sufficient to distinguish PTSD, complex PTSD, and dissociative presentations from primary mood or anxiety disorders.

Anyone presenting with “depression” or “anxiety” is screened for bipolarity with the MDQ, for adult ADHD with the ASRS, and for OCD with the Y-BOCS. These are the diagnoses that most commonly get missed in a 15-minute primary-care visit — and misdiagnosis is the single most common reason first-line antidepressants fail. Baseline labs (CBC, CMP, TSH, B12, folate, vitamin D) are ordered where indicated, because untreated hypothyroidism and B12 deficiency mimic treatment-resistant depression more often than clinicians expect.

Full-length evaluations of this kind are the foundation of specialty psychiatric medication management. This is the visit primary care does not have room to run.

Measurement-based care and why it changes outcomes

Symptom scales at RECO are not paperwork — they are the instrument the treatment plan is calibrated to. PHQ-9 for depression, GAD-7 for anxiety, MDQ for bipolar screening, ASRS for adult ADHD, and Y-BOCS for OCD are completed by the client before each visit, scored in the visit, and tracked longitudinally in the chart.

The published evidence is unambiguous: measurement-based care produces meaningfully better outcomes than clinical impression alone, particularly in depression and anxiety. A four-point drop on the PHQ-9 is a clinically meaningful response; remission is a sustained score under five. Medication decisions — dose changes, augmentation, cross-class switching, escalation to rTMS or Spravato — are anchored to the scale trajectory rather than to whether the client says they “feel better today.” That distinction matters most when a client is subjectively discouraged but the numbers are actually moving, or subjectively fine but the trajectory has stalled short of remission.

The pharmacologic toolkit beyond the first two SSRIs

First-line pharmacotherapy is well-established. SSRIs and SNRIs for unipolar depression and anxiety disorders. Stimulants and non-stimulants — atomoxetine, viloxazine, guanfacine — for ADHD. Mood stabilizers and second-generation antipsychotics — lithium, valproate, lamotrigine, quetiapine, lurasidone, aripiprazole — for bipolar disorder. SSRIs paired with an ERP referral for OCD. Where a first-line agent works and is tolerated, the plan is straightforward.

The value of specialty psychiatry is what happens after first-line fails. Augmentation strategies — aripiprazole at low dose, lithium at 300-900 mg, T3 thyroid, buspirone — are deployed with the evidence base a rushed primary-care visit does not have time to weigh. Switching within class (sertraline to escitalopram) and across class (SSRI to SNRI to mirtazapine to bupropion) is done with intent rather than by trial-and-error. MAOIs remain on the table for genuinely treatment-resistant depression when the washout is done properly. Pharmacogenomic panels (GeneSight, Genomind) are ordered in complex non-responders where CYP2D6 or CYP2C19 phenotype could reshape the decision.

Where oral pharmacotherapy has been optimized without adequate response, escalation to interventional treatment — rTMS delivered at 3000 pulses per session at 120% of motor threshold, or Spravato (esketamine) under REMS-registered supervision — is coordinated on-site rather than deferred to an outside referral.

Monitoring: the labs, the metabolic panel, the drug levels

Monitoring is the part of medication management that most consistently gets neglected in general practice, and where the downstream consequences are most preventable. Lithium requires baseline TSH, creatinine, and calcium, plus quarterly serum levels held to a therapeutic window of 0.6-1.0 mEq/L for maintenance and 0.8-1.2 mEq/L for acute mania — with renal and thyroid rechecks every six to twelve months.

Second-generation antipsychotics — quetiapine, olanzapine, aripiprazole, lurasidone — require baseline and annual metabolic monitoring: HbA1c, fasting lipid panel, weight, waist circumference, and blood pressure. Olanzapine and quetiapine in particular carry meaningful metabolic risk that has to be tracked rather than assumed away. Valproate requires baseline LFTs, platelets, and serum levels dosed toward 50-125 mcg/mL. Stimulants require a cardiovascular history at baseline and a blood pressure and heart rate check at every follow-up visit.

RECO’s protocol builds each of these into the visit cadence. Nothing depends on the client remembering to ask, and no result is left in an inbox unreviewed.

What to expect on your first visit

Intake paperwork — demographics, insurance, release of information, and the baseline symptom scales — is sent electronically before the appointment and reviewed by the psychiatrist in advance. Clients are asked to bring bottles of every current medication and, where possible, a list of every prior psychiatric medication with approximate dose and duration. That single step accelerates the diagnostic formulation more than any other piece of preparation.

The evaluation itself is unhurried by design. The goal is a defensible DSM-5-TR formulation, an evidence-based treatment plan discussed with the client rather than announced at them, and — where indicated — same-day electronic prescriptions and lab orders routable to any Quest or LabCorp draw station near PGA National or the Gardens Mall. Follow-up visits are typically 30 minutes and structured around the scale data, side-effect review, and the specific decision point in the pharmacologic algorithm.

Insurance and logistics from Palm Beach Gardens

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. Benefits are verified before the first visit so that copay, coinsurance, deductible status, and any prior-authorization requirements are known in advance rather than after the fact. Out-of-network superbills are issued on request.

The drive from PGA National, BallenIsles, Mirasol, Frenchman’s Reserve, or Old Palm to the Delray Beach office runs 25 miles and roughly 35 minutes via I-95 southbound to Atlantic Avenue. Once a stable regimen is established, most Palm Beach Gardens clients transition a portion of their follow-ups to secure Florida-licensed telepsychiatry — DEA-registered for controlled prescriptions where appropriate — and reserve in-person visits for evaluations, dose escalations, and clinical checkpoints where an in-room exam matters.

Serving residents of: BallenIsles, Frenchman's Reserve, Mirasol, Old Palm, PGA National.